An investigation into combined amorphous form of sufadoxine, pyrimethamine and azithromycin
Year: 2021
Type: dissertation
Abstract: An investigation into combined amorphous form of sulfadoxine, pyrimethamine and azithromycin.Background:Malaria remains one of the top mortality causes in the sub-Saharan African region, especially among pregnant women and infants.Despite several measures being implemented within the affected areas such as the use of treated mosquito nets, sulfadoxine and pyrimethamine (SUL-PYR) as an intermittent preventive treatment (IPTp-SP) is still considered the standard prophylactic regimen for pregnant women.Recently, the WHO increased the regimen of IPTp-SP from three to four doses on a monthly interval, this recommendation poses a potential risk of toxicity and resistance to the drugs.An improvement towards this challenge is under clinical trial and consists of the inclusion of azithromycin (AZI), a macrolide antibiotic, to the current IPTp-SP treatment regimen.This will not only aid in the prophylaxis of malaria in pregnant women but will also assist in other pregnancy related infections.All three these drugs exhibit poor aqueous solubility; requiring high concentrations for oral administration to achieve therapeutic plasma concentrations.This in itself is a risk to patients and when considering the addition of another dosage form to the IPTp-SP regimen the issue of reduced adherence due to the high "pill burden" may potentially contribute to antiprotozoal and antimicrobial resistance. Aim:It is a proven fact that amorphous solid-state forms of drugs exhibit superior aqueous solubility over their respective crystalline forms.The current study undertook investigation of combining SUL, PYR and AZI into a ternary amorphous solid-state form as potential solution to the poor solubility of the three drugs which could potentially also have a positive effect on dose reduction and reduced pill-burden. Methods:A physical mixture consisting of SUL, PYR and AZI in the ratio of 1 : 0.05 : 1 w/w/w termed SPA-C was prepared as a control preparation.Quench cooling of the melt and solvent evaporation techniques were investigated as solid-state form preparation techniques in an effort to convert SPA-C to an amorphous solid-state form.The physicochemical properties of the individual drugs, SPA-C as well as the resulting solid-state form preparations were http://etd.uwc.ac.za/VI analysed utilising hot-stage microscopy (HSM), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), vapour sorption analysis, equilibrium solubility and dissolution rate testing.To aid in the equilibrium solubility and dissolution rate testing, a novel HPLC method capable of simultaneously detecting and quantifying all three compounds was developed and validated. Results:Thermal, spectroscopic and XRPD analyses confirmed that a ternary amorphous solid-state system consisting of SUL, PYR and AZI was successfully prepared using the quench cooling of the melt method.The physico-chemical characterisation of this amorphous solid-state form was compared to that of pure crystalline SUL, PYR and AZI as well as to SPA-C.Amorphous solid-state forms are known to be metastable forms thus providing higher solubility concentrations and increased dissolution rates but with the drawback of decreased physical stability.Solubility and dissolution data obtained for the prepared ternary amorphous solidstate form elucidated solubility increases of 1681.9, 37.4 and 711.8% respectively for SUL, PYR and AZI and increases of over 100% in terms of dissolution rates for each of the three drugs in distilled water, as opposed to the individual crystalline counterparts.In this study improved stability of the ternary amorphous form was proven in comparison with that of the reported neat amorphous forms of SUL and AZI. Conclusion:These findings concluded the possibility to prepare a novel ternary amorphous system which exhibits superior physical stability and improved aqueous solubility and dissolution rate, showing that the possibility to prepare ternary amorphous systems using only active pharmaceutical ingredients is possible.
Author: Okello, Geoffrey
Institution: University of the Western Cape
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7010700347
